{"&cites=12894171158113881425&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","url":"https://ard.bmj.com/content/73/3/492.short","authors":["JS Smolen","JS Smolen R Landewé","JS Smolen R Landewé FC Breedveld…"],"year":2014,"numCitations":2331,"pdf":"https://ard.bmj.com/content/annrheumdis/73/3/492.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=15630718529220191090&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ciNJ7q9369gJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15630718529220191090&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com","p":1,"exp":1596893544121},{"title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs","url":"https://ard.bmj.com/content/69/6/964.short","authors":["JS Smolen","JS Smolen R Landewé","JS Smolen R Landewé FC Breedveld…"],"year":2010,"numCitations":2113,"pdf":"https://ard.bmj.com/content/annrheumdis/69/6/964.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=18242945375836507497&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:aQ2X_yn2K_0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=18242945375836507497&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com"},{"title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.23721","authors":["KG Saag","KG Saag GG Teng","KG Saag GG Teng NM Patkar…"],"year":2008,"numCitations":1781,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.23721","citationUrl":"http://scholar.google.com/scholar?cites=17112596124214357976&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:2O-FMIInfO0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=17112596124214357976&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library"},{"title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","url":"https://ard.bmj.com/content/76/6/960.abstract","authors":["JS Smolen","JS Smolen R Landewé","JS Smolen R Landewé J Bijlsma…"],"year":2017,"numCitations":1810,"pdf":"http://eprints.whiterose.ac.uk/116927/1/annrheumdis-2016-210715.pdf","citationUrl":"http://scholar.google.com/scholar?cites=532213958404936786&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:UhQ7f8bNYgcJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=532213958404936786&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com"},{"title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","url":"https://www.sciencedirect.com/science/article/pii/S0163725807002069","authors":["D Tracey","D Tracey L Klareskog","D Tracey L Klareskog EH Sasso","D Tracey L Klareskog EH Sasso JG Salfeld…"],"year":2008,"numCitations":1650,"citationUrl":"http://scholar.google.com/scholar?cites=848955606561904576&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:wNcyT6AYyAsJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=848955606561904576&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.30129","authors":["DT Felson","DT Felson JS Smolen","DT Felson JS Smolen G Wells","DT Felson JS Smolen G Wells B Zhang…"],"year":2011,"numCitations":1363,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.30129","citationUrl":"http://scholar.google.com/scholar?cites=12290633109847859973&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:BeMi4bEZkaoJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12290633109847859973&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library"},{"title":"Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial","url":"https://www.sciencedirect.com/science/article/pii/S0140673608603049","authors":["G D'Haens","G D'Haens F Baert","G D'Haens F Baert G Van Assche","G D'Haens F Baert G Van Assche P Caenepeel…"],"year":2008,"numCitations":1178,"pdf":"http://www.academia.edu/download/42192191/DHaens_G._et_al._Early_combined_immunos20160205-14055-w4wga2.pdf","citationUrl":"http://scholar.google.com/scholar?cites=10609437650928893926&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:5n9FElVLPJMJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10609437650928893926&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"New therapies for treatment of rheumatoid arthritis","url":"https://www.sciencedirect.com/science/article/pii/S0140673607607843","authors":["JS Smolen","JS Smolen D Aletaha","JS Smolen D Aletaha M Koeller","JS Smolen D Aletaha M Koeller MH Weisman…"],"year":2007,"numCitations":1072,"citationUrl":"http://scholar.google.com/scholar?cites=8216520489830012329&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:qVUJPtrxBnIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8216520489830012329&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including …","url":"https://ard.bmj.com/content/66/1/34.short","authors":["B Combe","B Combe R Landewé","B Combe R Landewé C Lukas","B Combe R Landewé C Lukas HD Bolosiu…"],"year":2007,"numCitations":1058,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc1798412/","citationUrl":"http://scholar.google.com/scholar?cites=12377824672075394548&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:9K0eb_XdxqsJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12377824672075394548&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com"},{"title":"Adverse effects of biologics: a network meta‐analysis and Cochrane overview","url":"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008794.pub2/abstract","authors":["JA Singh","JA Singh GA Wells","JA Singh GA Wells R Christensen…"],"year":2011,"numCitations":916,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173749/","citationUrl":"http://scholar.google.com/scholar?cites=1220869869955191328&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:IBKoo61m8RAJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1220869869955191328&hl=en&as_sdt=2005&sciodt=0,5","publication":"cochranelibrary.com"}]}